There is always lots to worry about, but AI is not one of them
By Chris Bailey | Wednesday 7 June 2023
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I was pleased to read earlier today that the “European Commission authorises GSK's (GSK) Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults”. A bit more positive progress by one of the better value FTSE 100 names for boring personal pension fund investors such as me. Elsewhere, I also read that “BHP (BHP) and Microsoft use AI to lift Escondida copper recovery”. Another company feels obligated to mention then how so ahead of the norm it is on artificial intelligence.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.